Although the roles of STOX1 in glioma have not yet been clarified, our study predicts that STOX1 may be used as a biomarker to assist in the diagnosis and treatment of glioma, and it could also be used as a prognostic marker for glioma patients. Here, STOX1 is linked to central nervous system cancer.